Analysis of active surveillance data indicates rising rates of resistance mechanisms in varied hospital settings, highlighting the need for urgent interventions.
Key Points
Positive tests for carbapenemase-producing enterobacterales rose by 60% in the Non-Intensive Area from 2020 to 2023, indicating an alarming trend.
The most commonly detected resistance mechanism was KPC, found in approximately 80% of positive cases among 366 detected samples.
The protocol involved screening rectal swabs on chromogenic media and performing the XpertCarba-R assay for positive identification.
Effective monitoring through active surveillance can help inform antibiotic therapy and infection control measures in healthcare settings.